Previous Close | 24.32 |
Open | 24.32 |
Bid | 0.00 x 900 |
Ask | 0.00 x 800 |
Day's Range | 23.50 - 24.67 |
52 Week Range | 17.19 - 30.14 |
Volume | |
Avg. Volume | 708,713 |
Market Cap | 2.579B |
Beta (5Y Monthly) | 0.55 |
PE Ratio (TTM) | 24.45 |
EPS (TTM) | 0.98 |
Earnings Date | Feb 13, 2023 - Feb 17, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 34.20 |
Subscribe to Yahoo Finance Plus to view Fair Value for CORT
In this article we are going to estimate the intrinsic value of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) by...
Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since approval. However, sole dependence on Korlym for revenues remains a headwind.
Durect (DRRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.